Drug Shortage Report for KEVZARA
| Report ID | 188465 |
| Drug Identification Number | 02460548 |
| Brand name | KEVZARA |
| Common or Proper name | KEVZARA 200 |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SARILUMAB |
| Strength(s) | 200MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 2 |
| ATC code | L04AC |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-03-31 |
| Estimated end date | 2023-04-10 |
| Actual end date | 2023-04-04 |
| Shortage status | Resolved |
| Updated date | 2023-04-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-04-04 | French | Compare |
| v4 | 2023-04-04 | English | Compare |
| v3 | 2023-04-01 | English | Compare |
| v2 | 2023-03-31 | French | Compare |
| v1 | 2023-03-31 | English | Compare |
Showing 1 to 5 of 5